You are viewing the site in preview mode

Skip to main content

Table 2 Risk factors associated with developing an SSI

From: Incidence and root causes of surgical site infections after gastrointestinal surgery at a public teaching hospital in Sudan

Variables Total Patients with SSI P value
Sex Male 43 (50.4%) 13 (30.2%) 0.555
  Female 37 (49.7%) 9 (24.3%)  
Medical comorbidities No 54 (67.5%) 12 (22.2%) 0.128
  Yes 26 (32.5%) 10 (38.5%)  
Surgical condition Non malignant 52 (65.0%) 5 (9.60%) > 0.001
  Malignant 28 (35.0%) 17 (60.7%)  
Bowel preparation No 41 (51.3%) 9 (22.0%) 0.254
  Yes 39 (48.8%) 13 (33.3%)  
Second antibiotic dose No 76 (95.0%) 20 (26.3%) 0.301
  Yes 4 (5.0%) 2 (50.0%)  
Site of operation Small bowel 16 (20.0%) 8 (50.0%) 0.074
  Large bowel 37 (46.3%) 6 (16.2%)  
  Biliary 25 (31.3%) 7 (28.0%)  
  Pancreatic 2 (2.5%) 1 (50.0%)  
Classification of surgery Clean 2 (2.5%) 1 (50.0%) 0.746
  Clean-contaminated 39 (48.8%) 11 (28.2%)  
  Contaminated 39 (48.8%) 10 (25.6%)  
Intra-operative hypotension No 39 (48.8%) 6 (15.4%) 0.018
  Yes 41 (51.3%) 16 (39.0%)  
Duration of operation Less than 3 hours 60 (70.6%) 8 (14.3%) > 0.001
  More than 3 hours 25 (29.4%) 14 (58.3%)  
Intra-operative blood loss No blood loss 48 (60.0%) 4 (8.30%) > 0.001
  Less than 500 ml 18 (22.5%) 9 (50.0%)  
  More than 500 ml 7 (8.5%) 3 (42.9%)  
Type of antibiotics prophylaxis 2nd generation cephalosporin 40 (50.0%) 10 (25.0%) 0.383
  Metronidazol + 2nd generation cephalosporin 35 (43.8%) 11 (31.4%)  
  Metronidazol 4 (5%) 0  
\